Triple-action diabetes jab shown to reduce blood sugar and body weight

Retatrutide is designed to control appetite and blood sugar but also increase body’s energy expenditure, unlike other drugs A new triple-action weekly jab for type 2 diabetes could significantly reduce blood sugar and body weight, according to phase 3 trial results. Patients in the trial (…)